{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T02:28:10Z","timestamp":1786328890601,"version":"build-2736575974"},"reference-count":142,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education and Science of Russia","award":["FURG-2026-0027 (126031018585-0)"],"award-info":[{"award-number":["FURG-2026-0027 (126031018585-0)"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Prostate cancer (PCa) is one of the most prevalent malignancies in men worldwide. Established clinicopathological parameters do not fully describe the biological heterogeneity of PCa or consistently predict its clinical course after radical prostatectomy, supporting the investigation of additional prognostic markers. Stroma AReactive Invasion Front Areas (SARIFA) is a recently described histomorphological pattern characterized by direct contact between tumor cells and adipocytes without intervening desmoplastic or inflammatory stroma at the invasion front. Limited retrospective evidence from prostatectomy specimens indicates that SARIFA positivity is associated with adverse pathological features. However, its independent prognostic value and clinical utility remain to be established. Because SARIFA can potentially be assessed on routinely prepared hematoxylin and eosin-stained sections without additional molecular assays or immunohistochemical staining, it represents a potentially accessible candidate marker, although its reproducibility, standardization, and cost-effectiveness require formal evaluation. This review summarizes current evidence concerning lipid metabolic remodeling and tumor\u2013adipocyte interactions that may contribute to the SARIFA phenotype in PCa. Androgen receptor-regulated lipid metabolism, uptake of adipocyte-derived fatty acids, adipokine signaling, and extracellular vesicle-mediated communication provide a plausible mechanistic framework. Nevertheless, direct experimental evidence linking several of these processes specifically to SARIFA in PCa remains limited, and some proposed relationships are based on indirect evidence or findings from other tumor types. Further studies should establish standardized scoring criteria, intra- and interobserver reproducibility, external validation, and incremental prognostic value before the clinical implementation of SARIFA can be considered.<\/jats:p>","DOI":"10.3390\/life16081304","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:20:03Z","timestamp":1786324803000},"page":"1304","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SARIFA and Lipid Metabolic Reprogramming in Prostate Cancer: Fundamental Mechanisms, Tumor Microenvironment, and Novel Biomarker Prospects"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2052-914X","authenticated-orcid":false,"given":"Liudmila","family":"Mikhaleva","sequence":"first","affiliation":[{"name":"Petrovsky National Research Centre of Surgery, 117418 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Martynova","sequence":"additional","affiliation":[{"name":"State Budgetary Healthcare Institution \u201cRepublican Pathology Bureau\u201d of the Ministry of Health of the Republic of North Ossetia\u2014Alania, 362003 Vladikavkaz, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5456-8692","authenticated-orcid":false,"given":"Zarina","family":"Gioeva","sequence":"additional","affiliation":[{"name":"Petrovsky National Research Centre of Surgery, 117418 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3386-7746","authenticated-orcid":false,"given":"Nikolay","family":"Shakhpazyan","sequence":"additional","affiliation":[{"name":"Petrovsky National Research Centre of Surgery, 117418 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Chizhikov","sequence":"additional","affiliation":[{"name":"Moscow Botkin Multidisciplinary Scientific-Clinical Center, 125284 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5896-4556","authenticated-orcid":false,"given":"Valentina","family":"Pechnikova","sequence":"additional","affiliation":[{"name":"Petrovsky National Research Centre of Surgery, 117418 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1041-8561","authenticated-orcid":false,"given":"Mikhail","family":"Gushchin","sequence":"additional","affiliation":[{"name":"Petrovsky National Research Centre of Surgery, 117418 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4675-0766","authenticated-orcid":false,"given":"Alexander","family":"Ilyichev","sequence":"additional","affiliation":[{"name":"Petrovsky National Research Centre of Surgery, 117418 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,9]]},"reference":[{"key":"ref_1","unstructured":"Ervik, M., Laversanne, M., Lam, F., Colombet, M., Ferlay, J., Filho, A.M., and Bray, F. (2026). Global Cancer Observatory: Cancer Today (2024 Estimates, Version 1.0)\u2014Prostate Fact Sheet, International Agency for Research on Cancer. Available online: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/cancers\/27-prostate-fact-sheet.pdf."},{"key":"ref_2","unstructured":"Jacques, F., Ervik, M., Lam, F., Colombet, M., Mery, L., Pi\u00f1eros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2024). Global Cancer Observatory: Cancer Tomorrow. Version 1.1, International Agency for Research on Cancer. Available online: https:\/\/gco.iarc.who.int\/tomorrow\/en\/dataviz\/isotype?cancers=27&single_unit=50000&years=2040&types=0."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The Lancet Commission on prostate cancer: Planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"key":"ref_4","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kie\u0142b, P., Kowalczyk, K., Gurwin, A., Nowak, \u0141., Krajewski, W., Sosnowski, R., Szyde\u0142ko, T., and Ma\u0142kiewicz, B. (2023). Novel Histopathologi-cal Biomarkers in Prostate Cancer: Implications and Perspectives. Biomedicines, 11.","DOI":"10.3390\/biomedicines11061552"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/path.5810","article-title":"Stroma AReactive Invasion Front Areas (SARIFA)\u2014A new prognostic biomarker in gastric cancer related to tumor-promoting adipocytes","volume":"256","author":"Grosser","year":"2021","journal-title":"J. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41698-024-00662-2","article-title":"The SARIFA biomarker in the context of basic research of lipid-driven cancers","volume":"8","author":"Reitsam","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Martin, B., Grosser, B., Kempkens, L., Miller, S., Bauer, S., Dhillon, C., Banner, B.M., Brendel, E.-M., Sipos, \u00c9., and Vlasenko, D. (2021). Stroma AReactive Invasion Front Areas (SARIFA)-a new easily to determine biomarker in colon can-cer-results of a retrospective study. Cancers, 13.","DOI":"10.3390\/cancers13194880"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41417-023-00695-y","article-title":"Novel biomarker SARIFA in colorectal cancer: Highly prognostic, not genetically driven and histologic indicator of a distinct tumor biology","volume":"31","author":"Reitsam","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Grochowski, P., Grosser, B., Sommer, F., Probst, A., Waidhauser, J., Schenkirsch, G., Reitsam, N.G., and M\u00e4rkl, B. (2024). The Concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12519-9"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41416-023-02515-4","article-title":"Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial","volume":"130","author":"Grosser","year":"2024","journal-title":"Br. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Enke, J.S., Gro\u00df, M., Grosser, B., Sipos, E., Steinestel, J., L\u00f6hr, P., Waidhauser, J., Lapa, C., M\u00e4rkl, B., and Reitsam, N.G. (2024). SARIFA as a new his-topathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid me-tabolism, and might predict a metastatic pattern in pT3a prostate cancer. BMC Cancer, 24.","DOI":"10.1186\/s12885-023-11771-9"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"ISUP Grading Workshop Panel Members. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma","volume":"44","author":"Grignon","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_14","unstructured":"European Association of Urology (2026, August 03). EAU Guidelines on Prostate Cancer\u2014Diagnostic Evaluation. Uroweb. Available online: https:\/\/uroweb.org\/guidelines\/prostate-cancer\/chapter\/diagnostic-evaluation."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.19.02768","article-title":"Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline","volume":"38","author":"Eggener","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ajur.2019.12.003","article-title":"Lipogenic Effects of Androgen Signaling in Normal and Malignant Prostate","volume":"7","author":"Mah","year":"2020","journal-title":"Asian J. Urol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sacca, P.A., and Calvo, J.C. (2022). Periprostatic adipose tissue microenvironment: Metabolic and hormonal pathways during prostate cancer progression. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.863027"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41585-023-00764-9","article-title":"Obesity and prostate cancer\u2014Microenvironmental roles of adipose tissue","volume":"20","author":"Saha","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e70067","DOI":"10.1002\/biof.70067","article-title":"Extracellular Vesicles Released from Prostate Cancer Cells Confer Pro-Tumor Properties to Adipocytes by Stimulating Lipolysis","volume":"51","author":"Giannitti","year":"2025","journal-title":"Biofactors"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Fontana, F., Anselmi, M., Carollo, E., Sartori, P., Procacci, P., Carter, D., and Limonta, P. (2022). Adipocyte-Derived Extracellular Vesicles Promote Prostate Cancer Cell Aggressiveness by Enabling Multiple Phenotypic and Metabolic Changes. Cells, 11.","DOI":"10.3390\/cells11152388"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s10020-026-01422-7","article-title":"Periprostatic adipose tissue-derived extracellular vesicles modulate prostate cancer cell behaviour in vitro according to tumor grade","volume":"32","author":"Altamirano","year":"2026","journal-title":"Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"101913","DOI":"10.1016\/j.tranon.2024.101913","article-title":"Stroma AReactive Invasion Front Areas (SARIFA): A novel histopathologic biomarker in colorectal cancer patients and its association with the luminal tumor proportion","volume":"44","author":"Reitsam","year":"2024","journal-title":"Transl. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Reitsam, N.G., M\u00e4rkl, B., Dintner, S., Sipos, E., Grochowski, P., Grosser, B., Sommer, F., Eser, S., Nerlinger, P., and Jordan, F. (2023). Alterations in natural killer cells in colorectal cancer patients with stroma AReactive invasion front areas (SARIFA) Cancers. Cancers, 15.","DOI":"10.3390\/cancers15030994"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00292-026-01547-w","article-title":"SARIFA: Literatur\u00fcbersicht und Expertenmeinung zum neuen morphologischen Biomarker [SARIFA: Literature review and expert opinion on the new morphological biomarker]","volume":"47","author":"Adam","year":"2026","journal-title":"Pathologie"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1200\/JCO.2015.63.3651","article-title":"Biomarker: Predictive or Prognostic?","volume":"33","author":"Ballman","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.abb.2016.04.014","article-title":"A Comprehensive Review of the Role of Zinc in Normal Prostate Function and Metabolism; and Its Implications in Prostate Cancer","volume":"611","author":"Costello","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41419-025-07460-z","article-title":"Estrogen-related receptor alpha (ERR\u03b1) controls the stemness and cellular energetics of prostate cancer cells via its direct regulation of citrate metabolism and zinc transportation","volume":"16","author":"Ma","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101516","DOI":"10.1016\/j.molmet.2022.101516","article-title":"Multiple Metabolic Pathways Fuel the Truncated Tricarboxylic Acid Cycle of the Prostate to Sustain Constant Citrate Production and Secretion","volume":"62","author":"Lacouture","year":"2022","journal-title":"Mol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-4598-5-14","article-title":"Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues","volume":"5","author":"Singh","year":"2006","journal-title":"Mol. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0303-7207(03)00205-3","article-title":"Androgens Stimulate Coordinated Lipogenic Gene Expression in Normal Target Tissues in Vivo","volume":"205","author":"Heemers","year":"2003","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"\u0160kara, L., Hu\u0111ek Turkovi\u0107, A., Pezelj, I., Vrtari\u0107, A., Sin\u010di\u0107, N., Kru\u0161lin, B., and Ulamec, M. (2021). Prostate Cancer\u2014Focus on Cholesterol. Cancers, 13.","DOI":"10.3390\/cancers13184696"},{"key":"ref_32","first-page":"2220","article-title":"Alpha-methylacyl-CoA racemase: A new molecular marker for prostate cancer","volume":"62","author":"Luo","year":"2002","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/pros.20177","article-title":"Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer","volume":"63","author":"Zha","year":"2004","journal-title":"Prostate"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Parupathi, P., Devarakonda, L.S., Francois, E., Amjed, M., and Kumar, A. (2025). Reprogrammed Lipid Metabolism-Associated Therapeutic Vulnerabilities in Prostate Cancer. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26189132"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1158\/1541-7786.MCR-11-0206","article-title":"Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells","volume":"10","author":"Huang","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"ref_36","first-page":"159634","article-title":"DHA suppresses hormone-sensitive and castra-tion-resistant prostate cancer growth by decreasing de novo lipogenesis","volume":"1870","author":"Tamarindo","year":"2025","journal-title":"Biochim. Biophys. Acta (BBA) \u2014Mol. Cell Biol. Lipids"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.56434\/j.arch.esp.urol.20247703.30","article-title":"Low-Density Lipoprotein Cholesterol and Prostate Cancer: A Retrospective Study","volume":"77","author":"Hu","year":"2024","journal-title":"Arch. Esp. Urol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Li, Y., Wu, S., Zhao, X., Hao, S., Li, F., Wang, Y., Liu, B., Zhang, D., Wang, Y., and Zhou, H. (2023). Key Events in Cancer: Dysregulation of SREBPs. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1130747"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s12276-023-01079-w","article-title":"Functional Significance of Cholesterol Metabolism in Cancer: From Threat to Treatment","volume":"55","author":"Xiao","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Guerra, B., Recio, C., Aranda-Tav\u00edo, H., Guerra-Rodr\u00edguez, M., Garc\u00eda-Castellano, J.M., and Fern\u00e1ndez-P\u00e9rez, L. (2021). The Mevalonate Pathway, a Metabolic Target in Cancer Therapy. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.626971"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41389-023-00460-8","article-title":"Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: A promising target in anti-cancer therapies","volume":"12","author":"Vanauberg","year":"2023","journal-title":"Oncogenesis"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41416-024-02762-z","article-title":"Metabolic adaptations in prostate cancer","volume":"131","author":"Carracedo","year":"2024","journal-title":"Br. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/s41416-022-02096-8","article-title":"The role of PPAR\u03b3 in prostate cancer development and progression","volume":"128","author":"Hartley","year":"2023","journal-title":"Br. J. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2009.11.027","article-title":"Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis","volume":"140","author":"Nomura","year":"2010","journal-title":"Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"18944","DOI":"10.1038\/s41598-019-55418-x","article-title":"FABP5 coordinates lipid signaling that promotes prostate cancer metastasis","volume":"9","author":"Carbonetti","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Joshi, M., Stoykova, G.E., Salzmann-Sullivan, M., Dzieciatkowska, M., Liebman, L.N., Deep, G., and Schlaepfer, I.R. (2019). CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions. Cells, 8.","DOI":"10.3390\/cells8101115"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"112396","DOI":"10.1016\/j.celrep.2023.112396","article-title":"AMPK activation protects against prostate cancer by inducing a catabolic cellular state","volume":"42","author":"Penfold","year":"2023","journal-title":"Cell Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e2412244","DOI":"10.1002\/advs.202412244","article-title":"Combined Blockade of Lipid Uptake and Synthesis by CD36 Inhibitor and SCD1 siRNA Is Beneficial for the Treatment of Refractory Prostate Cancer","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1073\/pnas.1808834116","article-title":"Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer","volume":"116","author":"Zadra","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12967-023-03874-5","article-title":"FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma","volume":"21","author":"Chianese","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"100797","DOI":"10.1016\/j.eclinm.2021.100797","article-title":"First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors","volume":"34","author":"Falchook","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref_52","unstructured":"David, N. (2025, November 21). A Phase I, Open-Label, Dose-Finding Study of TVB-2640 Administered in Combination with Enzalutamide (Xtandi) in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC). ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05743621."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1158\/0008-5472.CAN-23-1489","article-title":"ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain Ferroptosis","volume":"84","author":"Shrestha","year":"2024","journal-title":"Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s43018-025-00952-z","article-title":"CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors","volume":"6","author":"Chen","year":"2025","journal-title":"Nat. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1038\/s41467-020-16126-7","article-title":"2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer","volume":"11","author":"Blomme","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41416-023-02557-8","article-title":"Peroxisomal \u03b2-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer","volume":"130","author":"Mah","year":"2024","journal-title":"Br. J. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41388-022-02498-1","article-title":"TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer","volume":"42","author":"Fan","year":"2023","journal-title":"Oncogene"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/s43018-024-00838-6","article-title":"The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1","volume":"5","author":"Romero","year":"2024","journal-title":"Nat. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/pros.24680","article-title":"Cancer cells employ lipid droplets to survive toxic stress","volume":"84","author":"Kostecka","year":"2024","journal-title":"Prostate"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41585-024-00869-9","article-title":"Unlocking ferroptosis in prostate cancer\u2014The road to novel therapies and imaging markers","volume":"21","author":"Cao","year":"2024","journal-title":"Nat. Rev. Urol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis","volume":"117","author":"Yi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.21873\/cgp.20110","article-title":"Human periprostatic adipose tissue: Secretome from patients with prostate cancer or benign prostate hyperplasia","volume":"16","author":"Sacca","year":"2019","journal-title":"Cancer Genom. Proteom."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/03008880510030932","article-title":"Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens","volume":"216","author":"Epstein","year":"2005","journal-title":"Scand. J. Urol. Nephrol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/1541-7786.MCR-18-0748","article-title":"Periprostatic Adipose Tissue Favors Prostate Cancer Cell Invasion in an Obesity-Dependent Manner: Role of Oxidative Stress","volume":"17","author":"Laurent","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Cussenot, O., Poupel, L., Mousset, C., Lavergne, J., Bruyere, F., Fontaine, A., Cancel-Tassin, G., and Fromont-Hankard, G. (2024). Spatial genomics identifies heat shock proteins as key molecular changes associated to adipose periprostatic space invasion in prostate cancer. Cancers, 17.","DOI":"10.3390\/cancers17010002"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"119101","DOI":"10.1016\/j.bbamcr.2021.119101","article-title":"Adipocyte-driven unfolded protein response is a shared transcriptomic signature of metastatic prostate carcinoma cells","volume":"1868","author":"Herroon","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/er.2010-0030","article-title":"Paracrine and endocrine effects of adipose tissue on cancer development and progression","volume":"32","author":"Park","year":"2011","journal-title":"Endocr. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1038\/s41598-017-04951-8","article-title":"Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease","volume":"7","author":"Dahran","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"20896","DOI":"10.1038\/s41598-024-71862-w","article-title":"MRI-measured periprostatic to subcutaneous adipose tissue thickness ratio as an independent risk factor in prostate cancer patients undergoing radical prostatectomy","volume":"14","author":"Jiang","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Wu, X.H., Ke, Z.B., Chen, Z.J., Liu, W.Q., Xue, Y.T., Chen, S.H., Chen, D.N., Zheng, Q.S., Xue, X.Y., and Wei, Y. (2024). Periprostatic fat magnetic resonance imaging based radiomics nomogram for predicting biochemical recurrence-free survival in patients with non-metastatic prostate cancer after radical prostatectomy. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-13207-4"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Adesunloye, B.A. (2021). Mechanistic Insights into the Link between Obesity and Prostate Cancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22083935"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbabio.2010.11.004","article-title":"Role of obesity-associated dysfunctional adipose tissue in cancer: A molecular nutrition approach","volume":"1807","author":"Bustos","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/stem.1857","article-title":"Concise review: The obesity cancer paradigm: Exploration of the interactions and crosstalk with adipose stem cells","volume":"33","author":"Strong","year":"2015","journal-title":"Stem Cells"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13045-019-0778-6","article-title":"Cancer-associated adipocytes: Key players in breast cancer progression","volume":"12","author":"Wu","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"\u00c1lvarez-Artime, A., Garc\u00eda-Soler, B., Sainz, R.M., and Mayo, J.C. (2021). Emerging Roles for Browning of White Adipose Tissue in Prostate Cancer Malignant Behaviour. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115560"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2152\/jmi.65.9","article-title":"Adipose tissue: Critical contributor to the development of prostate cancer","volume":"65","author":"Uehara","year":"2018","journal-title":"J. Med. Investig."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jcyt.2013.11.012","article-title":"Human adipose-derived mesenchymal stromal cell pigment epithelium-derived factor cytotherapy modifies genetic and epigenetic profiles of prostate cancer cells","volume":"16","author":"Zolochevska","year":"2014","journal-title":"Cytotherapy"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1089\/scd.2011.0247","article-title":"Pigment epithelialderived factor and melanoma differentiation associated gene-7 cytokine gene therapies delivered by adipose-derived stromal\/ mesenchymal stem cells are effective in reducing prostate cancer cell growth","volume":"21","author":"Zolochevska","year":"2012","journal-title":"Stem Cells Dev."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Altuna-Coy, A., Ruiz-Plazas, X., S\u00e1nchez-Martin, S., Ascaso-Til, H., Prados-Saavedra, M., Alves-Santiago, M., Bernal-Escot\u00e9, X., Segarra-Tom\u00e1s, J., and Chac\u00f3n, M.R. (2022). The lipidomic profile of the tumoral periprostatic adipose tissue reveals alterations in tumor cell\u2019s metabolic crosstalk. BMC Med., 20.","DOI":"10.1186\/s12916-022-02457-3"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1080\/01635581.2020.1792946","article-title":"Leptin promotes prostate cancer proliferation and migration by stimulating STAT3 pathway","volume":"73","author":"Gorrab","year":"2021","journal-title":"Nutr. Cancer"},{"key":"ref_81","first-page":"202","article-title":"Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression","volume":"2","author":"Grant","year":"2013","journal-title":"Transl. Androl. Urol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/bju.12452","article-title":"Inflammation and prostate cancer: The role of interleukin 6 (IL-6)","volume":"113","author":"Nguyen","year":"2014","journal-title":"BJU Int."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Drewa, J., Lazar-Juszczak, K., Adamowicz, J., and Juszczak, K. (2025). Periprostatic adipose tissue as a contributor to prostate cancer pathogenesis: A narrative review. Cancers, 17.","DOI":"10.3390\/cancers17030372"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.eururo.2012.11.013","article-title":"Obesity and prostate cancer: Weighing the evidence","volume":"63","author":"Allott","year":"2013","journal-title":"Eur. Urol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1158\/1940-6207.CAPR-10-0229","article-title":"Body mass index, prostate cancer-specific mortality, and biochemical recurrence: A systematic review and me-ta-analysis","volume":"4","author":"Cao","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1258\/ebm.2012.012131","article-title":"Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma","volume":"237","author":"Ribeiro","year":"2012","journal-title":"Exp. Biol. Med."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Scioli, M.G., Storti, G., D\u2019amico, F., Gentile, P., Kim, B.-S., Cervelli, V., and Orlandi, A. (2019). Adipose-derived stem cells in cancer progression: New perspectives and opportunities. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133296"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1111\/jcmm.16511","article-title":"Adipose-derived mesenchymal stem cells induced PAX8 promotes ovarian cancer cell growth by stabilizing TAZ protein","volume":"25","author":"Chu","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"8540535","DOI":"10.1155\/2022\/8540535","article-title":"MAPK\/ERK-CBP-RFPL-3 mediates adiposederived stem cell-induced tumor growth in breast cancer cells by activating telomerase reverse transcriptase expression","volume":"2022","author":"Li","year":"2022","journal-title":"Stem Cells Int."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1002\/1878-0261.12998","article-title":"Cyr61 from adipose-derived stem cells promotes colorectal cancer metastasis and vasculogenic mimicry formation via integrin alpha(V) beta(5)","volume":"15","author":"Liang","year":"2021","journal-title":"Mol. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/stem.3050","article-title":"Adipose stem cells and cancer: Concise review","volume":"37","author":"Sabol","year":"2019","journal-title":"Stem Cells"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e12404","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesi-cles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1126\/science.308.5730.1862","article-title":"Cell biology: The ins and outs of exosomes","volume":"308","author":"Couzin","year":"2005","journal-title":"Science"},{"key":"ref_94","first-page":"234","article-title":"Extracellular vesicles in prostate cancer: Current understanding and future perspectives","volume":"6","author":"Perumalsamy","year":"2026","journal-title":"J. Natl. Cancer Cent."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1158\/0008-5472.CAN-16-0651","article-title":"Adipocyte Exosomes Promote Melanoma Aggressiveness through Fatty Acid Oxidation: A Novel Mechanism Linking Obesity and Cancer","volume":"76","author":"Lazar","year":"2016","journal-title":"Cancer Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e102525","DOI":"10.15252\/embj.2019102525","article-title":"Adipocyte extracellular vesicles carry enzymes and fatty acids that stimulate mitochondrial metabolism and remodeling in tumor cells","volume":"39","author":"Clement","year":"2020","journal-title":"EMBO J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"81880","DOI":"10.18632\/oncotarget.18737","article-title":"Adipocyte-derived exosomes promote lung cancer metastasis by increasing MMP9 activity via transferring MMP3 to lung cancer cells","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s13105-019-00692-6","article-title":"Adipose-derived exosomes deliver miR-23a\/b to regulate tumor growth in hepatocellular cancer by targeting the VHL\/HIF axis","volume":"75","author":"Liu","year":"2019","journal-title":"J. Physiol. Biochem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1305677","DOI":"10.1080\/20013078.2017.1305677","article-title":"Characterisation of adipocyte-derived extracellular vesicle subtypes identifies distinct protein and lipid signatures for large and small extracellular vesicles","volume":"6","author":"Durcin","year":"2017","journal-title":"J. Extracell. Vesicles"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/pcmedi\/pbaa007","article-title":"Clinical applications of exosome membrane proteins","volume":"3","author":"Hu","year":"2020","journal-title":"Precis. Clin. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jconrel.2015.06.029","article-title":"Exosome mediated communication within the tumor microenvironment","volume":"219","author":"Milane","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcdb.2015.02.010","article-title":"Extracellular vesicles in cancer: Exosomes, microvesicles and the emerging role of large oncosomes","volume":"40","author":"Minciacchi","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Duan, H., Xu, B., Luo, P., Chen, T., and Zou, J. (2025). Exosomal non-coding RNAs: Orchestrators of intercellular crosstalk in the prostate cancer tumor microenvironment. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1644861"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41419-020-03382-0","article-title":"Extracellular vesicles-released parathyroid hormone-related protein from Lewis lung carcinoma induces lipolysis and adipose tissue browning in cancer cachexia","volume":"12","author":"Hu","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_105","first-page":"1301","article-title":"Exosomal miR-155 from gastric cancer induces cancer-associated cachexia by suppressing adipogenesis and promoting brown adipose differentiation via C\/EPB\u03b2","volume":"19","author":"Liu","year":"2022","journal-title":"Cancer Biol. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"29159","DOI":"10.3402\/jev.v4.29159","article-title":"Characterisation of adipocyte-derived extracellular vesicles released pre- and post-adipogenesis","volume":"4","author":"Connolly","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/pros.24524","article-title":"Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile","volume":"83","author":"Hao","year":"2023","journal-title":"Prostate"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1159\/000541881","article-title":"The Immune Microenvironment in Prostate Cancer: A Comprehensive Review","volume":"103","author":"Novysedlak","year":"2025","journal-title":"Oncology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2562220","DOI":"10.1080\/2162402X.2025.2562220","article-title":"Characterization of the immune landscape in healthy mouse prostate and during prostate cancer progression","volume":"14","author":"Pervizou","year":"2025","journal-title":"Oncoimmunology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1200\/JCO.19.01638","article-title":"Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study","volume":"38","author":"Antonarakis","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41416-025-02972-z","article-title":"Stroma AReactive Invasion Front Areas (SARIFA), tumor immune microenvironment, and survival in colorectal cancer","volume":"132","author":"Tapiainen","year":"2025","journal-title":"Br. J. Cancer"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10120-023-01436-8","article-title":"Stroma AReactive Invasion Front Areas (SARIFA) proves prognostic relevance in gastric carcinoma and is based on a tumor-adipocyte interaction indicating an altered immune response","volume":"27","author":"Grosser","year":"2023","journal-title":"Gastric Cancer"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s43856-024-00589-6","article-title":"Converging deep learning and human-observed tumor-adipocyte interaction as a biomarker in colorectal cancer","volume":"4","author":"Reitsam","year":"2024","journal-title":"Commun. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"9949","DOI":"10.1038\/s41467-024-54364-1","article-title":"Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer","volume":"15","author":"Kiviaho","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"110668","DOI":"10.1016\/j.isci.2024.110668","article-title":"Multiplex imaging of localized prostate tumors reveals altered spatial organization of AR-positive cells in the microenvironment","volume":"27","author":"Ak","year":"2024","journal-title":"iScience"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/s42003-024-07161-x","article-title":"Spatial transcriptomics reveals strong association between SFRP4 and extracellular matrix remodeling in prostate cancer","volume":"7","author":"Andersen","year":"2024","journal-title":"Commun. Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2602324","DOI":"10.1080\/07853890.2025.2602324","article-title":"Patient-derived organoids based on targeted biopsy of primary prostate cancer: Development, identification, and drug screening","volume":"57","author":"Qian","year":"2025","journal-title":"Ann. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"101424","DOI":"10.1016\/j.mtbio.2024.101424","article-title":"ECM-mimicking hydrogel models of human adipose tissue identify deregulated lipid metabolism in the prostate cancer-adipocyte crosstalk under antiandrogen therapy","volume":"30","author":"Bessot","year":"2024","journal-title":"Mater. Today Bio"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Jiang, L., Khawaja, H., Tahsin, S., Clarkson, T.A., Miranti, C.K., and Zohar, Y. (2024). Microfluidic-based human prostate-cancer-on-chip. Front. Bioeng. Biotechnol., 12, Erratum in Front. Bioeng. Biotechnol. 2024, 12, 1520130. https:\/\/doi.org\/10.3389\/fbioe.2024.1520130.","DOI":"10.3389\/fbioe.2024.1302223"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aah4199","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Ku","year":"2017","journal-title":"Science"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41419-022-05211-y","article-title":"Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss","volume":"13","author":"Keam","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41746-021-00427-2","article-title":"Interpretable survival prediction for colorectal cancer using deep learning","volume":"4","author":"Wulczyn","year":"2021","journal-title":"npj Digit. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e2254891","DOI":"10.1001\/jamanetworkopen.2022.54891","article-title":"Pathologist Validation of a Machine Learning-Derived Feature for Colon Cancer Risk Stratification","volume":"6","author":"Wulczyn","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41591-022-02134-1","article-title":"Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer","volume":"29","author":"Foersch","year":"2023","journal-title":"Nat. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2589-7500(23)00208-X","article-title":"End-to-end prognostication in colorectal cancer by deep learning: A retrospective, multicentre study","volume":"6","author":"Jiang","year":"2024","journal-title":"Lancet Digit. Health"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/1078-0432.CCR-24-3656","article-title":"Validation of a Digital Pathology-Based Multimodal Artificial Intelligence Biomarker in a Prospective, Real-World Prostate Cancer Cohort Treated with Prostatectomy","volume":"31","author":"Bjartell","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e2400653","DOI":"10.1200\/PO-24-00653","article-title":"Digital Pathology\u2013Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men with Nonmetastatic Castration-Resistant Prostate Cancer","volume":"9","author":"Feng","year":"2025","journal-title":"JCO Precis. Oncol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"108318","DOI":"10.1016\/j.compbiomed.2024.108318","article-title":"RAPHIA: A deep learning pipeline for the registration of MRI and whole-mount histopathology images of the prostate","volume":"173","author":"Shao","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Bang, S., Ahn, Y.J., and Koo, K.C. (2025). Harnessing machine learning to predict prostate cancer survival: A review. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1502629"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"108804","DOI":"10.1016\/j.cmpb.2025.108804","article-title":"A systematic review of AI as a digital twin for prostate cancer care","volume":"268","author":"John","year":"2025","journal-title":"Comput. Methods Programs Biomed."},{"key":"ref_131","unstructured":"James, K., Paner, G., Al-Hussain, T., Brimo, F., Cimadamore, A., Eggener, S., Fine, S., Kristiansen, G., Leite, K.R.M., and Oxley, J. (2024). Prostate Cancer Histopathology Reporting Guide Radical Prostatectomy Specimen, International Collaboration on Cancer Reporting. [3rd ed.]. Available online: https:\/\/www.iccr-cancer.org\/datasets\/published-datasets\/urinary-male-genital\/prostate-rad-pros\/."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","article-title":"REporting recommendations for tumour MARKer prognostic studies (REMARK)","volume":"93","author":"McShane","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_133","unstructured":"FDA-NIH Biomarker Working Group (2026, August 05). Validation, BEST (Biomarkers, EndpointS, and Other Tools) Resource, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK464453\/."},{"key":"ref_134","unstructured":"US Food and Drug Administration (2024, May 01). Qualifying a Biomarker Through the Biomarker Qualification Program, Available online: https:\/\/www.fda.gov\/drugs\/biomarker-qualification-program\/qualifying-biomarker-through-biomarker-qualification-program."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.eururo.2024.01.002","article-title":"Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer","volume":"85","author":"Pope","year":"2024","journal-title":"Eur. Urol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"235.e11","DOI":"10.1016\/j.urolonc.2015.12.003","article-title":"Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer","volume":"34","author":"Meyer","year":"2016","journal-title":"Urol. Oncol."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Bourbonne, V., Fournier, G., Valli\u00e8res, M., Lucia, F., Doucet, L., Tissot, V., Cuvelier, G., Hue, S., Le Penn Du, H., and Perdriel, L. (2020). Ex-ternal Validation of an MRI-Derived Radiomics Model to Predict Biochemical Recurrence after Surgery for High-Risk Prostate Cancer. Cancers, 12.","DOI":"10.3390\/cancers12040814"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1007\/s00261-025-04892-1","article-title":"MRI-based radiomics for prediction of biochemical recurrence in prostate cancer: A systematic review and meta-analysis","volume":"50","author":"Salimi","year":"2025","journal-title":"Abdom. Radiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1016\/j.acra.2024.12.006","article-title":"MRI-based Radiomics for Predicting Prostate Cancer Grade Groups: A Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies","volume":"32","author":"Lomer","year":"2024","journal-title":"Acad. Radiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1007\/s00330-019-06114-x","article-title":"Correlation between MRI phenotypes and a genomic classifier of prostate cancer: Preliminary findings","volume":"29","author":"Purysko","year":"2019","journal-title":"Eur. Radiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"110534","DOI":"10.1016\/j.mri.2025.110534","article-title":"Combination of clinicopathological and MRI based radiomics features in predicting homologous recombination repair genes mutations in prostate cancer","volume":"124","author":"Chen","year":"2025","journal-title":"Magn. Reson. Imaging"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s43856-023-00282-0","article-title":"Predicting lymph node metastasis from primary tumor histology and clinicopathologic factors in colorectal cancer using deep learning","volume":"3","author":"Krogue","year":"2023","journal-title":"Commun. Med."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/8\/1304\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:32:52Z","timestamp":1786325572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/16\/8\/1304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,9]]},"references-count":142,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["life16081304"],"URL":"https:\/\/doi.org\/10.3390\/life16081304","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,9]]}}}